SCHEMBL32669847

SCHEMBL32669847

CN(Cc1cc(Cl)ccc1F)C(=O)/C(C#N)=C(\O)c1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.39
FTO Q9C0B1 1/20 0.39
S1PR3 Q99500 1/20 0.36
GABRA1 P14867 3/20 0.34
GABRG2 P18507 3/20 0.34
GABRB3 P28472 3/20 0.34
GABRB2 P47870 2/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
RIPK1 Q13546 1/20 0.33
HSD17B13 Q7Z5P4 1/20 0.33
ERCC1 P07992 1/20 0.33
ERCC4 Q92889 1/20 0.33
TTR P02766 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669498 0.97 COMT (0.39) COMTFTOS1PR3GABRA1GABRG2
SCHEMBL32669572 0.93 COMT (0.40) COMTFTOS1PR3GABRA1GABRG2
SCHEMBL32669600 0.92 ALDH1A1 (0.39) COMTFTOMAOAMAOBRIPK1
SCHEMBL32669838 0.91 COMT (0.35) COMTFTOS1PR3GABRA1GABRG2
SCHEMBL32669621 0.91 COMT (0.37) COMTFTOMAOAMAOBRIPK1
SCHEMBL32669695 0.90 COMT (0.35) COMTFTOS1PR3MRGPRX4MAOA
SCHEMBL32669758 0.89 COMT (0.36) COMTFTOMAOAMAOBRIPK1
SCHEMBL32670065 0.89 MCL1 (0.38) COMTFTOMEN1KMT2APOLB
SCHEMBL32669805 0.89 S1PR3 (0.42) COMTFTOS1PR3RIPK1MEN1
SCHEMBL32669543 0.85 FFAR1 (0.37) COMTFTORIPK1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 COMT 52/4885FTO 1/4885S1PR3 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.